APA (7th ed.) Citation

L, V., M, F., LA, N., JL, A., PS, G., M, d. S. F., . . . RM, M. (2014). Can we predict long-term remission after somatostatin analog withdrawal in patients with acromegaly? Results from a multicenter prospective trial. Endocrine, 46(3), 577. https://doi.org/10.1007/s12020-013-0094-9

Chicago Style (17th ed.) Citation

L, Vilar, Fleseriu M, Naves LA, Albuquerque JL, Gadelha PS, dos Santos Faria M, Nascimento GC, Montenegro RM Jr, and Montenegro RM. "Can We Predict Long-term Remission After Somatostatin Analog Withdrawal in Patients with Acromegaly? Results from a Multicenter Prospective Trial." Endocrine 46, no. 3 (2014): 577. https://doi.org/10.1007/s12020-013-0094-9.

MLA (9th ed.) Citation

L, Vilar, et al. "Can We Predict Long-term Remission After Somatostatin Analog Withdrawal in Patients with Acromegaly? Results from a Multicenter Prospective Trial." Endocrine, vol. 46, no. 3, 2014, p. 577, https://doi.org/10.1007/s12020-013-0094-9.